AROA Biosurgery Completes Randomised Controlled Trial for Symphony™; Preliminary Read-Out indicates Primary Endpoint Met
Go back to AROA Biosurgery Completes Randomised Controlled Trial for Symphony™; Preliminary Read-Out indicates Primary Endpoint Met| AEROFLEX HOLDING CORP. (NYSE: ARX) | Delayed: 13.11 -0.26 (1.94%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.37 | 52 Week High | $10.95 | |||
| Open | $13.17 | 52 Week Low | $6.70 | |||
| Day High | $13.36 | P/E | N/A | |||
| Day Low | $12.76 | EPS | $-1.11 | |||
| Volume | 1,696,770 | |||||
